Idoroenyi Amanam to Antibodies, Monoclonal
This is a "connection" page, showing publications Idoroenyi Amanam has written about Antibodies, Monoclonal.
Connection Strength
0.249
-
Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience. Cancer Med. 2023 05; 12(10):11248-11253.
Score: 0.195
-
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells. J Hematol Oncol. 2024 08 14; 17(1):67.
Score: 0.053